Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTS: Aliskiren and Valsartan on Retinal Vessel Structure
NCT01318395Phase 3Completed
- Sponsor
- FAU Erlangen-Nürnberg Medical Faculty
- Start
- May 2010
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aliskiren in hypertension (HTN), sponsored by FAU Erlangen-Nürnberg Medical Faculty. Started May 2010; status: completed.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01318395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01318395.